In vitro studies of prostate cancer reported that monocyte-induced cancer cell invasion mediates chemokine ligand 2 (monocyte chemotactic protein-1) and nuclear factor-κB activity [16] and that tumor stroma-derived factors skew monocyte to dendritic cell differentiation toward a suppressive phenotype [17]. This evidence concerns the gene CCL2 and prostate carcinoma.